SCHEMBL7325344

SCHEMBL7325344

N#Cc1cc(C(F)(F)F)nn1-c1ccc(NC(=O)c2ccccc2Cl)cc1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CRACR2A Q9BSW2 2/20 0.52
ORAI1 Q96D31 3/20 0.51
MAPT P10636 5/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
THRB P10828 2/20 0.49
TP53 P04637 3/20 0.49
STIM1 Q13586 2/20 0.48
TRPC1 P48995 1/20 0.48
TRPC3 Q13507 1/20 0.48
RORC P51449 1/20 0.47
LMNA P02545 1/20 0.47
MAPK1 P28482 1/20 0.47
RAB9A P51151 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
GRM4 Q14833 2/20 0.45
SMO Q99835 1/20 0.44
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7325414 0.89 ORAI1 (0.56) CRACR2AORAI1MAPTSMN1; SMN2THRB
SCHEMBL7326129 0.87 ORAI1 (0.60) CRACR2AORAI1MAPTSMN1; SMN2THRB
SCHEMBL7320259 0.85 ORAI1 (0.69) CRACR2AORAI1MAPTSMN1; SMN2THRB
SCHEMBL7313187 0.84 ORAI1 (0.51) CRACR2AORAI1MAPTSMN1; SMN2THRB
SCHEMBL7319433 0.81 ORAI1 (0.52) CRACR2AORAI1MAPTSMN1; SMN2THRB
SCHEMBL7321677 0.80 CRACR2A (0.66) CRACR2AORAI1MAPTSMN1; SMN2TP53
SCHEMBL7320590 0.80 CRACR2A (0.51) CRACR2AORAI1MAPTSMN1; SMN2THRB
SCHEMBL7323660 0.80 ORAI1 (0.75) CRACR2AORAI1MAPTSMN1; SMN2THRB
SCHEMBL7323503 0.78 ORAI1 (0.62) CRACR2AORAI1MAPTSMN1; SMN2THRB
SCHEMBL7326962 0.76 ORAI1 (0.66) CRACR2AORAI1MAPTSMN1; SMN2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US claimed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP claimed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO claimed
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed
EP-1068187-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 2001-01-17 EP disclosed
WO-1999051580-A1 PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES (US) 1999-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 CRACR2A 3286/4885ORAI1 3522/4885MAPT 2674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.